| First Author | Kim JH | Year | 2018 |
| Journal | Bone | Volume | 107 |
| Pages | 188-195 | PubMed ID | 29223746 |
| Mgi Jnum | J:257899 | Mgi Id | MGI:6113010 |
| Doi | 10.1016/j.bone.2017.12.005 | Citation | Kim JH, et al. (2018) BCAP promotes osteoclast differentiation through regulation of the p38-dependent CREB signaling pathway. Bone 107:188-195 |
| abstractText | Many studies have determined that PI3K-Akt signaling pathways play important roles in osteoclast differentiation and function. In the present study, we investigated the roles of B-cell adaptor for PI3K (BCAP), which is a PI3K binding molecule, in osteoclasts. Overexpression of BCAP in osteoclast precursor cells enhanced osteoclast differentiation induced by tumor necrosis factor alpha (TNF-alpha) as well as receptor activator of nuclear factor-kappaB ligand (RANKL). Conversely, osteoclast differentiation mediated by both cytokines was attenuated when BCAP expression was downregulated using small interfering RNA. Notably, BCAP induced Akt activation only upon stimulation by RANKL, but not by TNF-alpha. However, BCAP activated p38-dependent cAMP response element-binding protein (CREB) phosphorylation induced by both RANKL and TNF-alpha. Collectively, we showed that BCAP plays an important role in osteoclast differentiation by regulating the p38-dependent CREB signaling pathway, and that BCAP might be a new therapeutic target for bone diseases. |
